Current Medicinal Chemistry


Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge

Nobel Laureates on Editorial Board

Prof. John Gurdon

Prof. Jean-Marie Lehn

Prof. Ferid Murad

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 18 Issue: 11, April

Editorial [Hot Topic: Targeted Cancer Therapies: Current Status and Future Directions (Guest Editors: Ioannis Starakis)]

Volume:18   Issue: 11
Pp: 1573-1574
Ioannis Starakis
DOI: 10.2174/092986711795471356
Published on: 01 March, 2012

The Endocannabinoid System in the Cancer Therapy: An Overview

Volume:18   Issue: 11
Pp: 1575-1583
C. Grimaldi and A. Capasso
DOI: 10.2174/092986711795471374
Published on: 01 March, 2012

Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions

Volume:18   Issue: 11
Pp: 1584-1598
V.T. Labropoulou, A.D. Theocharis, A. Symeonidis, S.S. Skandalis, N.K. Karamanos and H.P. Kalofonos
DOI: 10.2174/092986711795471275
Published on: 01 March, 2012

Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges

Volume:18   Issue: 11
Pp: 1599-1612
A.K. Koutras, I. Starakis, U. Kyriakopoulou, P. Katsaounis, A. Nikolakopoulos and H.P. Kalofonos
DOI: 10.2174/092986711795471338
Published on: 01 March, 2012

Mechanisms of Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-Small-Cell Lung Cancer: Clinical and Molecular Considerations

Volume:18   Issue: 11
Pp: 1613-1628
A. Pallis, E. Briasoulis, H. Linardou, C. Papadimitriou, D. Bafaloukos, P. Kosmidis and S. Murray
DOI: 10.2174/092986711795471383
Published on: 01 March, 2012

Incorporation of Targeted Agents in the Management of Patients with Advanced Gastric Cancer

Volume:18   Issue: 11
Pp: 1629-1639
G. Pentheroudakis and A. Stoyianni
DOI: 10.2174/092986711795471365
Published on: 01 March, 2012

Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients

Volume:18   Issue: 11
Pp: 1640-1650
F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi and S. Barni
DOI: 10.2174/092986711795471310
Published on: 01 March, 2012

Targeted-Therapy in Advanced Renal Cell Carcinoma

Volume:18   Issue: 11
Pp: 1651-1657
M.T. Pirrotta, P. Bernardeschi and G. Fiorentini
DOI: 10.2174/092986711795471293
Published on: 01 March, 2012

Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics

Volume:18   Issue: 11
Pp: 1658-1671
B. Venugopal and T.R.J. Evans
DOI: 10.2174/092986711795471284
Published on: 01 March, 2012

Cinnamic Acid Derivatives as Anticancer Agents-A Review

Volume:18   Issue: 11
Pp: 1672-1703
P. De, M. Baltas and F. Bedos-Belval
DOI: 10.2174/092986711795471347
Published on: 01 March, 2012

Recent Advances in Studies on Hydroxamates as Matrix Metalloproteinase Inhibitors: A Review

Volume:18   Issue: 11
Pp: 1704-1722
R.K. Yadav, S.P. Gupta, P.K. Sharma and V.M. Patil
DOI: 10.2174/092986711795471329
Published on: 01 March, 2012

Iron Regulation in Tuberculosis Research: Promise and Challenges

Volume:18   Issue: 11
Pp: 1723-1731
A.K. Sharma, R. Naithani, V. Kumar and S.S. Sandhu
DOI: 10.2174/092986711795471301
Published on: 01 March, 2012